RXST peer analysis
RxSight (RXST) against its competitors: price, today's move, 1-year return and market value side by side.
- RXST's peers: BFLY (Butterfly Network), CERS (Cerus), DCTH (Delcath Systems), DMAC (DiaMedica Therapeutics), KIDS (OrthoPediatrics), NPCE (Neuropace), TCMD (Tactile Systems), TMCI (Treace Medical).
RXST and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BFLY Butterfly Network | $5.35 | -8.55% | 122.92% | $1.43B |
| CERS Cerus | $1.83 | -3.68% | 21.19% | $369.58M |
| DCTH Delcath Systems | $18.50 | -3.85% | 117.39% | $643.58M |
| DMAC DiaMedica Therapeutics | $8.26 | 2.99% | 13.15% | $445.69M |
| KIDS OrthoPediatrics | $31.74 | -2.37% | 90.97% | $828.75M |
| NPCE Neuropace | $7.95 | -2.33% | -43.62% | $273.89M |
| TCMD Tactile Systems | $25.63 | -1.39% | 5.78% | $574.15M |
| TMCI Treace Medical | $4.31 | -0.92% | 58.46% | $282.56M |
| RXST RxSight | $4.49 | -2.60% | -52.74% | $188.26M |